Home >
Medicine Info >
Lametec 50 MG Tablet DT
Loading interface...

Lametec 50 MG Tablet DT

Manufactured byCipla Ltd.
ContainsLamotrigine
Description
Lametec 50 MG Tablet DT is a medicine used in the treatment of epilepsy (a condition in which nerve cell activity in the brain is disturbed that affects the brain, causing fits) and bipolar disorder (a mental health problem characterized by extreme mood swings). This medicine works by reducing the abnormal excitation of the brain cells. Lametec 50 MG Tablet DT may cause common side effects such as dizziness, drowsiness, dryness in your mouth, nausea/vomiting, headache, etc. Consult your doctor if these symptoms persist or worsen. Lametec 50 MG Tablet DT should be taken exactly as directed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid discontinuing the treatment without consulting your doctor as it may increase the frequency of your seizures (fits). To avoid it, gradual dose reduction is necessary under your doctor’s supervision. Lametec 50 MG Tablet DT should be avoided if you are allergic to it. Inform your doctor if you have pre-existing heart, kidney, liver or mental health problems before beginning treatment with this medicine. Close evaluation with respect to your current medicines is necessary to avoid any undesired side effects. Lametec 50 MG Tablet DT is not recommended in children below 2 years of age (epilepsy) and 18 years of age (bipolar disorder). If you are pregnant, breastfeeding, or are planning a pregnancy, consult your doctor before taking this medication.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Lametec 50 MG Tablet DT

Lamictal 50 MG Tablet DT
Glaxosmithkline Pharmaceuticals Ltd.
Lamictin 50 MG Tablet DT
Rpg Life Sciences Ltd.
Lamidus 50 MG Tablet DT
Zydus Cadila
Lamogin 50 MG Tablet DT
Fdc Ltd.

Side effects

Major & minor side effects for Lametec 50 MG Tablet DT

  • Headache
  • Skin rash
  • Irritability
  • Dizziness
  • Drowsiness
  • Insomnia (Sleeplessness)
  • Shaking of hands or feet
  • Diarrhoea
  • Dry mouth
  • Nausea or Vomiting
  • Tiredness
  • Joint pain
  • Back pain

Uses of Lametec 50 MG Tablet DT

What is it prescribed for?

  • Epilepsy
  • Lennox-Gastaut Syndrome
  • Bipolar disorder
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required by Lametec 50 MG Tablet DT to show its effect is not clinically known.
  • How long do the effects of this medicine last?
    Lametec 50 MG Tablet DT remains effective for an approximate duration of eight days after intake.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with Lametec 50 MG Tablet DT due to the increased risk of side effects such as dizziness, drowsiness, confusion, and difficulty in concentration. Do not drive vehicles or operate machines if you experience such symptoms.
  • Is this a habit forming medicine?
    No habit-forming tendencies have been reported with Lametec 50 MG Tablet DT.
  • Can this medicine be taken during pregnancy?
    Lametec 50 MG Tablet DT may cause severe side effects in your developing foetus. This medicine is not recommended during pregnancy unless necessary. If you are pregnant, consult your doctor.
  • Can this medicine be taken while breast-feeding?
    Lametec 50 MG Tablet DT passes into breastmilk and may cause side effects in your breastfed infant. This medicine is not recommended during breastfeeding unless necessary. If you are breastfeeding, consult your doctor.

Allergy

Avoid Lametec 50 MG Tablet DT if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Lametec 50 MG Tablet DT may cause severe side effects in your developing foetus. This medicine is not recommended during pregnancy unless necessary. If you are pregnant, consult your doctor.

Breast-feeding

Lametec 50 MG Tablet DT passes into breastmilk and may cause side effects in your breastfed infant. This medicine is not recommended during breastfeeding unless necessary. If you are breastfeeding, consult your doctor.
General warnings

Suicidal tendency

Lametec 50 MG Tablet DT should be used with caution due to the increased risk of suicidal thoughts. Inform your doctor if you experience any changes in mood or behaviour.

Driving or operating machines

Lametec 50 MG Tablet DT may increase your risk of dizziness and sleepiness. If you experience such symptoms, do not drive vehicles or operate machines.

Withdrawal

Avoid abrupt discontinuation of Lametec 50 MG Tablet DT without consulting your doctor as it may increase the frequency of your seizures (fits). Your doctor will reduce the dose of this medicine slowly over a period to prevent any undesired effects.

Use in children

Epilepsy: Lametec 50 MG Tablet DT is not recommended for use in children below 2 years of age due to a lack of safety and efficacy data. Bipolar disorder: Lametec 50 MG Tablet DT is not recommended for use in children below 18 years of age due to a lack of safety and efficacy studies.

Folic acid deficiency

Lametec 50 MG Tablet DT may increase the risk of folic acid deficiency. Folic acid supplementation may be required during long-term treatment with this medicine.

Missed Dose

Try not to skip a dose of Lametec 50 MG Tablet DT. Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed one. Do not double the dose to compensate for a missed one.

Overdose

Do not take more than the prescribed dose. Contact your doctor if you suspect an overdose with Lametec 50 MG Tablet DT.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with Lametec 50 MG Tablet DT due to the increased risk of side effects such as dizziness, drowsiness, confusion, and difficulty in concentration. Do not drive vehicles or operate machines if you experience such symptoms.
Interaction with Medicine

Valproic Acid

Pentazocine

Phenytoin

Ethinyl Estradiol

Lithium

Pregabalin

Disease interactions

Depression

Lametec 50 MG Tablet DT should be used with caution due to the increased risk of depression and suicidal thoughts. Inform your doctor if you experience any changes in mood or behaviour while taking this medicine.

Skin diseases

Lametec 50 MG Tablet DT may cause severe skin reactions such as Stevens-Johnson syndrome (a rare and serious painful skin rash with blisters) and Toxic Epidermal Necrolysis (life-threatening skin problem that causes blistering and peeling of your skin). Inform your doctor if you experience such symptoms.

Liver Disease

Lametec 50 MG Tablet DT is metabolized and broken down by the liver and should be used with caution if you have pre-existing liver problems due to the increased risk of undesired side effects, resulting from the accumulation of this medicine in your body. Your liver function needs to be closely monitored and dose adjustments may be required based on your clinical condition.

Kidney disease

Lametec 50 MG Tablet DT is eliminated by kidneys and should be used with caution if you have pre-existing kidney problems due to the increased risk of side effects, resulting from the accumulation of this medicine in your body. Your kidney function needs to be closely monitored and dose adjustments may be required based on your clinical condition.

Heart Disease

Lametec 50 MG Tablet DT should be used with caution if you have pre-existing heart problems due to the increased risk of an irregular heartbeat. Your blood pressure and electrocardiogram (ECG) needs to be closely monitored.

Meningitis

Meningitis is a condition with inflammation (swelling) of the membranes lining your brain and spinal cord. Lametec 50 MG Tablet DT may increase your risk of meningitis and should be used with caution. Inform your doctor if you experience any symptoms of headache, fever, nausea, vomiting, etc.

Blood disorders

Lametec 50 MG Tablet DT may affect your blood cell count and may increase your risk of leukopenia (low white blood cell count), anaemia (low red blood cell count), thrombocytopenia (low platelet count), etc. Your blood cell count needs to be closely monitored.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Lametec 50 MG Tablet DT with or without food. Do not take more or less than the prescribed dose. Do not stop the use of this medicine without consulting your doctor as it may increase the frequency of your seizures (fits). Lametec 50 MG Tablet DT may increase your risk of suicidal thoughts. Consult your doctor if you experience any changes in mood or behaviour. Lametec 50 MG Tablet DT may lower your blood cell count. Your blood cell count needs to be closely monitored. Avoid consuming alcohol while taking Lametec 50 MG Tablet DT as it may cause drowsiness or dizziness. Avoid driving vehicles or operating machines if you experience any symptoms that may affect your alertness after taking Lametec 50 MG Tablet DT.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Lametec 50 MG Tablet DT works by inhibiting the abnormal excitation of brain cells and helps in preventing seizures (fits). The exact mechanism of action by which this medicine helps treat bipolar disorder is not known.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Triazine anticonvulsants

Schedule

Schedule H

Medicines.org.uk. 2021. Lamictal Dispersible - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 30 November 2021].

https://www.medicines.org.uk/emc/product/1286/smpc>

Medicines.org.uk. 2021. [online] Available at: < [Accessed 30 November 2021].

https://www.medicines.org.uk/emc/files/pil.1286.pdf>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 30 November 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020241s059,020764s052,022251s023lbl.pdf>

Drugs, H., 2021. Lamotrigine: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 30 November 2021].

https://medlineplus.gov/druginfo/meds/a695007.html>

nhs.uk. 2021. Lamotrigine: medicine to treat epilepsy and bipolar disorder. [online] Available at: < [Accessed 30 November 2021].

https://www.nhs.uk/medicines/lamotrigine/>

Ebs.tga.gov.au. 2021. TGA eBS - Product and Consumer Medicine Information Licence. [online] Available at: < [Accessed 30 November 2021].

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2011-PI-01295-3&d=20211130172310101>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 23 Dec 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.